The founder of Johnson Products Company, as he insists in his new memoir, “Afro Sheen: How I Revolutionized an Industry with ...
Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...
Healthcare conglomerate Johnson & Johnson kicked off its bankruptcy plan confirmation Tuesday, in its third attempt to ...
The 49-year-old legend scored a third-place finish in the Great American Race, his best showing since winning for the second ...
In a report released today, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price ...
Mike Johnson and House Republicans on Wednesday released their budget plan, which would raise the debt ceiling by $4 trillion ...
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
Our clients are passing away,” attorney James Onder told US Bankruptcy Judge Christopher Lopez on Tuesday, the start of a ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or ...
Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...
The January megadeals included transactions in the energy, financials, pharmaceuticals and materials sectors, signaling a ...